- A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma. Woo, I.S., Moon, d.o. .H., Shim, B.Y., Lee, M.A., Byun, J.H., Kim, K.W., Kang, J.H., Choi, M.G., Chung, I.S., Hong, Y.S., Park, S.Y., Lee, K.S. Jpn. J. Clin. Oncol. (2005)